Atlas Trials

Long-Term Follow-up Study for Patients Previously Treated With JCAR015

Clinical trial NCT02813252 · COMPLETED

Trial details

NCT number
NCT02813252
Sponsor
Juno Therapeutics, a Subsidiary of Celgene
Status
COMPLETED
Study type
OBSERVATIONAL
Acute Lymphoblastic Leukemia
Start date
2016-08-30
Primary completion
2021-10-22
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.